General Facts

Quality Use of Medicines

What is quality use of medicines?

Quality use of medicines means ensuring that medicines are used most effectively to achieve longer and better lives. This includes prescribing and providing access to the right medicine for each particular patient. Quality use will also require the use of other forms of treatment when these are more appropriate or complement the medicines prescribed. Quality use will further ensure that a prescribed medicine is having its intended effect and that the patient is using it properly.

What is the impact of improper use of medicines?

The National Health Survey of 1995 revealed that over 6.5 million Australians had taken a medication in the previous two weeks.1 Most people who use their prescribed medicine to treat an illness receive a major health benefit without significant complications. However, problems with medication may arise because of intentional abuse, misuse, interaction between drugs and side effects. In more serious cases, this can lead to hospitalisation or the need for further treatment. Inappropriate use of medicines in general can lead to patient discomfort, inadequate treatment or wastage of taxpayer funds.

Who defines "quality use"?

Governments, prescribers, educators and consumers all see quality use of medicines differently. In particular, doctors may consider that prescribing restrictions or guidelines limit their freedom to prescribe a medicine for an individual patient, given the individual's medical need, coexisting conditions and patient history. Similarly, governments and advisory bodies want to encourage what they see as best practice to improve health outcomes and contain cost. All parties agree that further research to aid the clinical judgement of doctors will assist the quality use of medicines.

Why is quality use of medicines difficult to achieve?

Quality use of medicines requires cooperation between healthcare providers and consumers, as well as quality information on the best paths of treatment. These factors are not always present. Quality use may be undermined if cost considerations are given undue emphasis over restoring the patient's health.

What has been done to improve the use of medicines?

Australia has had a national strategy on the quality use of medicines since 1992. The current strategy aims for a national approach involving all stakeholders. It further aims to improve knowledge about best practice and communicate this information to healthcare providers.2Programs implemented include the development of information for consumers on medicines, medication review kits for health professionals, and the development of a best practice model for managing medication in aged care facilities. The Government also funds the National Prescribing Service (NPS) to provide healthcare professionals with information on medicines.

What role has the medicines industry played in improving the quality use of medicines?

The peak body of Australia's medicines industry, Medicines Australia, has stated that its members are committed to the quality use of medicines. It has recently further enhanced its Code of Conduct to ensure that promotion of medicine includes the necessary information to assist doctors to prescribe appropriately and within the guidelines of the Pharmaceutical Benefits Scheme (PBS). The pharmaceutical industry also aids the quality use of medicines through the development of prescribing support programs and contributing to doctors' continuing medical education.

What impact will improved technology have on quality use of medicines?

The information technology revolution is already improving the use of medicines in several ways. It is providing doctors with better information to decide on the right treatment for a patient. Barcoding and scanning technology reduces the rate of medication errors by providing additional checks before a patient is given treatment. Finally, data technology also allows doctors to access a patient's previous clinical history, including other medications, before prescribing. There are still many opportunities to improve access to these technologies in the healthcare system and ensure patients receive the most appropriate treatment.

The Pfizer Australia View

1. Australian Institute of Health and Welfare, Australia’s Health 2002
2. Commonwealth of Australia 2002, National Strategy for the Quality Use of Medicines; and Quality Use of Medicines. Statement of Priorities and Strategic Action Plan 2001-2003